Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

 68.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 201.82
  • 52 Week Low: 68.25
  • Currency: UK Pounds
  • Shares Issued: 181.53m
  • Volume: 11,481
  • Market Cap: 124.35m

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -118.9% -103.5%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 4.9 4.9
Pr/Book 1.7  
Latest F'cast
Revenue 166.8% 8.4%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CREO Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-17 n/a (8.91) (7.30)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (17.58) (15.98)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.01 (18.62) (12.99)p n/a n/a n/a n/a 0.0%
31-Dec-20 9.43 (23.46) (12.99)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (15.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CREO Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 27.27 (28.22) (13.63)p n/a n/a n/a n/a 0.0%
31-Dec-23 30.07 (29.89) (13.50)p n/a n/a n/a n/a 0.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

CREO Company Announcements

LTIP Awards and PDMR Dealing 08-Aug-2022 07:00 RNS
Exercise of Options 04-Aug-2022 07:00 RNS
H1 2022 Trading Update 03-Aug-2022 07:00 RNS

Latest CREO Director Deals

Traded Action Notifier PriceAmountValue
03-Aug-22 Exercise of option John Bradshaw 76.00p 78,947 59,999.72
03-Aug-22 Exercise of option John Bradshaw 21.39p 27,000 5,775.03
01-Aug-22 Transfer From Christopher Paul Hancock 0.000p 2,354 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CREO Market Data

Currency UK Pounds
Share Price 68.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 201.82
52 Week Low 68.25
Volume 11,481
Shares Issued 181.53m
Market Cap 124.35m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
11.78% above the market average11.78% above the market average11.78% above the market average11.78% above the market average11.78% above the market average
21.05% above the sector average21.05% above the sector average21.05% above the sector average21.05% above the sector average21.05% above the sector average
Price Trend
92.83% below the market average92.83% below the market average92.83% below the market average92.83% below the market average92.83% below the market average
89.74% below the sector average89.74% below the sector average89.74% below the sector average89.74% below the sector average89.74% below the sector average
Income Not Available
Growth
47.26% above the market average47.26% above the market average47.26% above the market average47.26% above the market average47.26% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 11-Aug-2022

Time Volume / Share Price
16:22 10,000 @ 68.50p
16:05 7 @ 69.00p
15:38 50 @ 69.00p
15:37 50 @ 69.00p
14:46 14 @ 68.28p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page